Land: Storbritannien
Språk: engelska
Källa: MHRA (Medicines & Healthcare Products Regulatory Agency)
Ropivacaine hydrochloride
Advanz Pharma
N01BB09
Ropivacaine hydrochloride
2mg/1ml
Solution for injection
Perineural; Epidural
No Controlled Drug Status
Valid as a prescribable product
BNF: 15020100; GTIN: 5099602996267
R1 11-04-2012 Font Helvetica Neue Corpo 10 pt Interlinea 10 pt 020D461018 38 X 143 ROPIVACAINE 2 MG/ML SOLUTION FOR INJECTION FORMATO CHIUSO (mm) 286/143 X 420/38 DIMENSIONI (mm) Grammatura carta 40 gr/mq NERO BOZZA MOLTENI S.P.A. PACKAGE LEAFLET: INFORMATION FOR THE USER ROPIVACAINE 2 MG/ML SOLUTION FOR INJECTION Ropivacaine hydrochloride READ ALL OF THIS LEAFL ET CAREFULLY BEFORE YOU START USING THIS MEDICINE. - Keep this leafl et. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. - If any of the side effects gets serious, or if you notice any side effects not listed in this leafl et, please tell your doctor or pharmacist. IN THIS LEAFL ET: 1. What Ropivacaine is and what it is used for 2. Before you use Ropivacaine 3. How to use Ropivacaine 4. Possible side effects 5. How to store Ropivacaine 6. Further information This product will be referred to as Ropivacaine from here on. 1. WHAT ROPIVACAINE IS AND WHAT IT IS USED FOR Ropivacaine contains the active substance ropivacaine hydrochloride which is a type of medi- cine called local anaesthetic. Ropivacaine 2 mg/ml solution for injection is used in adults and children of all ages for acute pain management. It numbs (anaesthetises) parts of the body e.g. after surgery. 2. BEFORE YOU USE ROPIVACAINE YOU MUST NOT BE GIVEN ROPIVACAINE - if you are ALLERGIC (hypersensitive) TO ROPIVACAINE HYDROCHLORIDE, other so called local an- aesthetics of the amide type or any of the other ingredients of Ropivacaine, - if you have a DECREASE IN BLOOD VOLUME (hypovolaemia). This is measured by healthcare personnel. - for INJECTION INTO A BLOOD VESSEL to numb a specifi c area of your body, - for INJECTION INTO THE NECK OF THE WOMB to relieve pain during childbirth. TAKE SPECIAL CARE WITH ROPIVACAINE - In newborn children as they are more susceptible to Ropivacaine. - In children < 12 years as some Läs hela dokumentet
ROPIVACAINE 2 MG / ML SOLUTION FOR INJECTION Summary of Product Characteristics Updated 24-Sep-2014 | Concordia International - formerly AMCo 1. Name of the medicinal product Ropivacaine 2 mg / ml solution for injection 2. Qualitative and quantitative composition Ropivacaine 2 mg/ml: Each ml solution for injection contains 2 mg ropivacaine hydrochloride. Each 10 ml ampoule contains 20 mg ropivacaine hydrochloride. Each 20 ml ampoule contains 40 mg ropivacaine hydrochloride. Excipient: Ropivacaine 2 mg/ml: Each 10 ml ampoule contains 1.47 mmol (or 33.9 mg) of sodium. Each 20 ml ampoule contains 2.95 mmol (or 67.8 mg) of sodium. For a full list of excipients, see section 6.1. 3. Pharmaceutical form Solution for injection Clear, colourless, sterile, isotonic, isobaric aqueous solution for injection with a pH of 4.0 to 6.0. 4. Clinical particulars 4.1 Therapeutic indications Ropivacaine 2 mg/ml solution for injection is indicated for acute pain management In adults and children above 12 years of age: - Continuous epidural infusion or intermittent bolus administration during postoperative or labour pain - Field blocks - Continuous peripheral nerve block via a continuous infusion or intermittent bolus injections, e.g. postoperative pain management In infants from 1 year and children up to and including 12 years for: - Single and continuous peripheral nerve block In neonates, infants and children up to and including 12 years for (per- and postoperative) - Caudal epidural block - Continuous epidural infusion 4.2 Posology and method of administration Ropivacaine should only be used by, or under the supervision, of clinicians experienced in regional anaesthesia. POSOLOGY _ADULTS AND CHILDREN ABOVE 12 YEARS OF AGE _ The following table is a guide to dosage for the more commonly used blocks. The smallest dose required to produce an effective block should be used. The clinician's experience and knowledge of the patient's physical status are of importance when deciding the dose. INDICATION CONCENTRATION MG/ML VOLUME ML DOSE MG Läs hela dokumentet